KRAS and non-small cell lung carcinoma: Compared to NSCLC with fusion rearrangement mutations, the G12C KRAS group demonstrated a lower frequency of pleural metastasis and lymphangitic carcinomatosis and a higher frequency of brain and soft tissue metastasis.